IP Library Granted Patent US 9,175,906
Granted Patent B2
US 9,175,906 · App. 10/639,361 · Granted Nov 3, 2015

Drug particles from freezing onto a surface

Inventors: Brian D. Scherzer (Midland, MI); Jonathan C. Evans (Midland, MI); James E. Hitt (Midland, MI)
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
F26B17/284A61K9/14A61K9/1688A61K9/19A61K31/38F26B5/065A61K6/0008A61K9/145A61K9/1694A61K9/5089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,906
App. No.
10/639,361
Granted
Nov 3, 2015
Kind
B2
Abstract

The present invention is a method for preparing micron-sized or submicron-sized drug particles comprising contacting a solution comprising a poorly water soluble drug substance and at least one freezable organic solvent with a cold surface so as to freeze the solution; and removing the organic solvent. The resulting particles are also disclosed, as are several embodiments of an apparatus that can be used in performing the method of the present invention.

Claims (12)

1. A method for enhancing the dissolution rate of drug particles comprising:

(a) cooling a cold solid surface to less than 5° C.;

(b) selecting a freezable organic solvent with a freezing point close to the temperature of the cold surface and into which a poorly water soluble drug substance dissolves;

(c) dissolving the poorly water soluble drug substance in the freezable organic solvent into a solution;

(d) contacting the solution with the cold solid surface so as to freeze the solution, wherein the rate of freezing of the solution is determined by the difference between the freezing point of the freezable organic solvent and the temperature to which the cold solid surface is cooled in step (a); and

(e) removing the organic solvent, wherein the resulting particles have a mean volume average particle size from less than 0.05 microns to 24 microns, a surface area of at least 2 m 2 /g and exhibit an in vitro dissolution rate of at least 1.5 times better than that of the unprocessed drug.

2. The method according to claim 1 wherein the cold surface is cooled using a cryogenic solid, a cryogenic gas, a cryogenic liquid or a heat transfer fluid capable of reaching cryogenic temperatures.

3. The method according to claim 1 wherein the freezable organic solvent is selected from the group consisting of alcohols, ethers, halocarbons, hydrocarbons, halogenated hydrocarbons, aromatic hydrocarbons, esters, acetates, organic acids, amines, ketones, sulfones, nitriles, carbonates, and combinations thereof.

4. The method according to claim 1 wherein the mean volume average particle size of the particles after the particles are dispersed in water is from 0.05 microns to 150 microns.

5. The method according to claim 1 wherein the solution further comprises at least one stabilizer.

6. The method according to claim 5 wherein the stabilizer is selected from the group consisting of phospholipids, surfactants, polymeric surfactants, vesicles, polymers selected from copolymers, homopolymers and block polymers, dispersion aids, and combinations thereof.

7. The method according to claim 1 wherein step (b) is performed using sublimation or evaporation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2015
From: SCHERZER, BRIAN D.; EVANS, JONATHAN C.; HITT, JAMES E.
To: DOW GLOBAL TECHNOLOGIES INC.
Reel/Frame 035594/0672 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2009
From: DOW GLOBAL TECHNOLOGIES INC.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 023327/0934 →
Continuity (2)
Provisional Application 60440535 · Jan 15, 2003
Related Publication 20040137070A1 · Jul 15, 2004